The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid by unknown
Abstract The biogenesis and accumulation of the
beta amyloid protein (Ab) is a key event in the cas-
cade of oxidative and inflammatory processes that
characterises Alzheimer’s disease. The presenilins and
its interacting proteins play a pivotal role in the
generation of Ab from the amyloid precursor protein
(APP). In particular, three proteins (nicastrin, aph-1
and pen-2) interact with presenilins to form a large
multi-subunit enzymatic complex (c-secretase) that
cleaves APP to generate Ab. Reconstitution studies in
yeast and insect cells have provided strong evidence
that these four proteins are the major components of
the c-secretase enzyme. Current research is directed
at elucidating the roles that each of these protein play
in the function of this enzyme. In addition, a number
of presenilin interacting proteins that are not com-
ponents of c-secretase play important roles in modu-
lating Ab production. This review will discuss the
components of the c-secretase complex and the role
of presenilin interacting proteins on c-secretase
activity.
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Abbreviations
APP amyloid precursor protein
Ab beta amyloid
AICD APP intracellular domain
aph-1 anterior pharynx defective 1
pen-2 presenilin enhancer 2
PS1 presenilin 1
PS2 presenilin 2
TMP21 transmembrane protein 21
Introduction: the generation of beta amyloid by
presenilin and its binding proteins
Alzheimer’s disease (AD) is a complex, progressive
neurodegenerative disorder that is neuropathologically
characterised by extensive neuronal loss and the pres-
ence of neurofibrillary tangles and senile plaques.
While the majority of AD cases are sporadic, ~5% of
AD cases are familial (FAD) with mutations in three
genes, amyloid precursor protein, presenilin 1 (PS1)
and presenilin 2 (PS2) accounting for the majority of
cases. A major feature of both sporadic and familial
forms of AD, is the accumulation and deposition of a
small peptide referred to as beta amyloid (Ab) within
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brain tissue of AD sufferers. The mechanisms that
underlie the disease processes are poorly understood.
However, the accumulation of Ab is thought to play a
pivotal role in neuronal loss or dysfunction through a
cascade of events that include the generation of free
radicals, mitochondrial oxidative damage and inflam-
matory processes (reviewed in Refs. [1, 2]). The pri-
mary event that results in the abnormal accumulation
of Ab is thought to be the dysregulated proteolytic
processing of its parent molecule, the amyloid precur-
sor protein (APP).
The APP molecule is a transmembrane glycoprotein
that is proteolytically processed by two competing
pathways, the non-amyloidogenic and amyloidogenic
(Ab forming) pathways. How these pathways are reg-
ulated remains unclear. However, there are many fac-
tors including diet, hormonal status, and genetic
mutations that influence the processing of APP to
generate Ab (reviewed in Refs. [1, 3]). Three major
secretases are postulated to be involved in the proteo-
lytic cleavage of APP. These include a-secretase (of
which the metalloproteases ADAM17/TACE and
ADAM 10 are likely candidates), beta APP cleaving
enzyme (BACE, formally known as b-secretase) and
the c-secretase. The a-secretase cleaves within the Ab
domain of APP thus precluding the formation Ab and
generating non-amyloidogenic fragments and a
secreted form of APP (a-APPs). In the amyloidogenic
pathway (Fig. 1), BACE cleaves near the N-terminus of
the Ab domain on the APP molecule, liberating an-
other soluble form of APP, b-APPs and a C-terminal
fragment (C99) containing the whole Ab domain. The
final step in the amyloidogenic pathway is the intra-
membranous cleavage of the C99 fragment by c-secre-
tase, to liberate the Ab peptide (reviewed in Ref. [1]).
Identification of multiple cleavage sites within the APP
molecule has suggested the presence of other secreta-
ses, namely - and f-secretase; that generate the APP
intracellular domain (AICD) and a longer fragment of
Ab (Ab46), respectively [4–7]. Although different en-
zymes may exists, the same c-secretase complex that
generates Ab may also generate AICD and Ab46 as
these products are inhibited by c-secretase inhibitors
[4–7] indicating that this enzyme has multiple cleavage
sites. However, over-expression and mutagenesis stud-
ies have shown that the production of Ab and AICD
may be independent catalytic events [8, 9].
The c-secretase enzyme is thought to be an aspartyl
protease that has the unusual ability to regulate intra-
membrane proteolysis (RIP) for a growing list of type 1
integral membrane proteins which include, APP, APP
like proteins (APLPs), E-Cadherin, CD44, lipoprotein
receptor related protein (LRP), Notch, sterol regula-
tory element-binding protein (SREBP), interferon
response element (IRE1) and activated transcription
factor 6 (ATF-6) (for recent review see [10]). The
mechanism of RIP and c-secretase activity is unknown.
However a transient hydrophilic environment for
catalysis within the lipid membrane must be created.
Furthermore, the enzyme (or an enzyme domain) must
have the ability to bend and unwind the a-helical
substrates, exposing their amide bonds to hydrolysis. It
is therefore conceivable that the c-secretase enzyme is
an integral protein of the lipid bi-layer and contains a
number of proteins that may have different functions
within an enzyme complex. The exact conformation or
molecular architecture of the c-secretase enzyme
remains unknown. However, large molecular mass
complexes of ~250 kDa [11, 12], ~500 kDa [13–17] and
~2,000 kDa [13, 18] have been identified.
Over the last few years biochemical and genetic
approaches have identified four components of the c-
secretase complex, presenilins, nicastrin, anterior
pharynx defective (aph-1) and presenilin enhancer 2
(pen-2). Over-expression and expression knockdown
studies have provided strong evidence that these pro-
teins are essential for c-secretase activity [15, 19–24].
Subsequent reconstitution studies in non-mammalian
cells have provided evidence that these are the only
components responsible for c-secretase catalytic
activity [25–27]. However the active component and
the active catalytic site of this enzymatic complex are
yet to be identified.
The roles of presenilin and its binding partners within
the c-secretase complex in Ab generation
Presenilin 1: the catalytic component
of the c-secretase enzyme
Presenilin 1 (PS1) is thought to be the most critical
component of the c-secretase complex as evidence
indicates that it is the catalytic component of this pro-
teolytic enzyme. The finding that mutations in PS1
account for the majority of inherited early onset forms
of AD and result in the overproduction of the highly
amyloidogenic Ab42 [28–30] provided the initial
evidence that PS1 facilitates c-secretase activity. Sub-
sequent studies showed that PS1 ablation or mutagen-
esis of two highly conserved aspartate residues within
transmembrane domains 6 and 7 of PS1 results in a
reduction in Ab levels [31–34]. Furthermore, aspartyl
protease inhibitors and transition state analogue inhib-
itors which are designed to target the active site of the
protease, all reduce Ab40 and Ab42 levels and have
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been shown to affinity label and bind to PS1 [35–37]. In
addition, physical interactions between PS1 and the
APP-C99 fragment have been identified [38–40]. The
studies outlined above provide substantial evidence to
indicate that PS1 is the catalytic subunit of c-secretase.
However, this transmembrane protein is not typical of a
conventional aspartyl protease, and lacks the typical
D(T/S)G motif for an aspartyl protease active site
(recently reviewed in [41]. Aspartyl proteases require
the presence of two aspartate residues for the hydrolysis
of the peptide bond. Although PS1 lacks the typical
D(T/S)G aspartyl protease active site it does contain the
two aspartyl residues (D257 and D385) which are either
critical for the active site on the c-secretase complex or
constitute the active site [42]. Other proteases that
contain atypical aspartyl protease motifs and have weak
homology with PS1 include the bacterial membrane
embedded aspartyl protease, type 4 prepilin protease
and the signal peptidases, which are all transmembrane
proteins. These proteins share the unusual aspartyl
motif GxGD and perform intramembranous cleavage of
type I membrane proteins (reviewed in [43]). The
topology and atypical characteristics of these proteins
make them an unprecedented class of protease and as is
the case for PS1, would require interaction with of other
proteins within the complex.
The interaction between the components of the
c-secretase complex is not sufficient to create a mac-
romolecular enzyme complex such as c-secretase (i.e.
total mass of all the components is ~200 kDa). Thus,
Fig 1 Formation of the c-
secretase complex and Ab
generation. A schematic
representation of the
proposed formation of the c-
secretase complex and the
enzymatic activity resulting in
Ab generation. Evidence has
been provided to show that
PS, nicastrin (NCT), aph-1,
and pen-2 are the only
components of the c-secretase
complex. Nicastrin and aph-1
are involved in the early
formation of the complex,
interacting with each other
and forming a dimeric sub-
complex. The presenilin
holoprotein is incorporated




complex is transported to the
cell surface (or other Ab
generating compartments, i.e.
TGN) as a trimeric complex.
Pen-2 is incorporated into the
complex and presenilin is
cleaved forming the active c-
secretase complex. Following
cleavage of APP by BACE to





processing (RIP) by the c-
secretase complex, liberating
Ab1–40 or Ab1–42 (Modified
from Ref. [165])
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dimer or trimer formation must occur within the
complex. To date the only member of the complex that
is known to undergo this process is PS1. The full length
PS1 protein is rapidly endoproteolytically cleaved
within its characteristic large hydrophilic loop into
amino- and carboxy-terminal fragments (NTF/CTF) of
~27 and ~17 kDa, respectively [44, 45]. These frag-
ments are thought to interact with each other to form
the catalytic component of the c-secretase enzyme
since in the absence of full length PS1, co-expressed
NTF and CTF were able to generate c-secretase
activity in presenilin deficient mammalian cells [46, 47].
The stoichiometry and the nature of the interaction
between these fragments remain unclear. It has been
shown by many studies that the NTF:CTF form a
heterodimer in mammalian cells [12, 48–51] leading to
suggestions that this heterodimer is the active c-sec-
retase [52]. However, Cervantes and colleagues [53]
provided evidence that the presenilin fragments can
form a tetramer by identifying heterodimers as well as
NTF and CTF homodimers in yeast. Evidence for
heterodimer and NTF homodimer (but not CTF
homodimer) formation has been provided by photo-
affinity labelled cross-linking studies [54]. This forma-
tion provides a core of aspartyl residues required for
aspartyl protease activity. However, it has yet to be
established whether the hypothetical ‘‘core’’ is formed
between fragments from one PS1 molecule or multiple
molecules within the complex. Further, if PS1 is the
‘‘catalytic core’’ of the c-secretase complex the roles of
the other interacting proteins need to be determined.
Nicastrin: the substrate docking site and scaffolding
for building the c-secretase complex
Nicastrin was discovered to be part of the c-secretase
complex when it was found to co-immunoprecipitate
with PS1 [55]. Nicastrin is a type I transmembrane
protein with a 670 amino acid long hydrophilic N-ter-
minal domain, a transmembrane domain, and a rela-
tively short cytoplasmic C-terminus of twenty amino
acid residues [55]. The protein undergoes glycosylation
and sialylation within the secretory pathway to yield a
mature ~150 kDa protein, the largest component of the
c-secretase complex [14], [56–58]. Nicastrin has been
shown to be a critical component of the c-secretase
complex as inhibition of nicastrin function in vitro and
in vivo results in a complete loss of APP and Notch
cleavage [14, 55, 59–61]. Within this complex, nicastrin
appears to be involved in the early formation of the
complex, particularly in the formation of the first sub-
complex between itself and aph-1 (Fig. 1). Recent
evidence suggests that nicastrin is critical for the cor-
rect assembly of the c-secretase complex within the
endoplasmic reticulum and the intracellular trafficking
of the complex to the cell surface [62, 63]. Further-
more, nicastrin is essential for the interaction between
the complex and APP-C99 and thus may act as a
receptor for c-secretase substrates [63, 64]. Therefore,
although nicastrin is a critical component, evidence to
date suggests that it is unlikely to be a catalytic com-
ponent of the c-secretase complex. Instead, nicastrin
acts as a scaffold for the building of the active complex,
and a possible substrate docking site.
Anterior pharynx defective 1 (aph-1): scaffolding
partner for nicastrin and may have possible catalytic
activity
The aph-1 protein is a ~30 kDa, 308 amino acid long
7-transmembrane protein [65] existing in two homol-
ogous forms, located on chromosome 1 and chromo-
some 15 (aph-1a & aph-1b respectively; [19]). In
addition, as the result of alternate splicing, a long and
short isoform of aph-1a have also been reported, with
the short isoform more abundantly expressed in most
tissues [21]. Although the exact function of these iso-
forms remains unknown, multiple c-secretase com-
plexes containing aph-1 isoforms are thought to exist
[66, 67]. The aph-1a isoform appears to be incorpo-
rated into active c-secretase complexes. Deletion of
aph-1a causes a reduction in Ab generation [66] and is
the major isoform present in c-secretase complexes
during embryonic development [67]. The c-secretase
complexes incorporating aph-1b are thought to have a
redundant function as aph-1b has been found not to be
involved in the regulation of other c-secretase com-
ponents or c-secretase activity [66].
The aph-1 protein forms a stable and intermediate
~140 kDa complex with Nicastrin, before binding PS1.
Aph-1 has been shown to interact with immature and
mature forms of presenilins and nicastrin [21]. The
GXXXG motif located within transmembrane 4 of aph-
1 has been shown to be important in this interaction
[68], [69]. The aph-1: nicastrin sub-complex appears to
play a role in the stabilisation and assembly of PS1 in
the c-secretase complex (Fig 1; [24, 70, 68]). However,
the exact role of aph-1 in the c-secretase complex
remains unknown. Expression studies have shown that
removal of aph-1 destabilises the presenilin holoprotein
and the addition of aph-1 leads to the accumulation of
the holoprotein [11, 19–24, 71]. Thus together with
nicastrin, aph-1 is thought to contribute the initial for-
mation and trafficking of the c-secretase complex and
thereby provide a scaffold for the proteolytic processing
of PS1 and the formation of the active site.
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Aph-1 is critical for the activity of the fully
constructed c-secretase complex. Evidence has been
provided that as well as binding to immature compo-
nents of c-secretase in early stages of complex forma-
tion, aph-1 also interacts with the mature forms of PS1,
nicastrin and pen-2 [68, 72]. Furthermore, recent
evidence has been provided to suggest that this inter-
action occurs on the cell surface where it also binds the
c-secretase substrate, Notch and facilitates its cleavage
[72]. These studies suggest that apart from the scaf-
folding function it shares with nicastrin, aph-1 has an-
other function within the fully constructed, active
c-secretase complex. Structural and functional simi-
larities between aph-1 and other proteases that possess
the ability for intramembranous cleavage (such as
rhomboid, [68, 73] suggests that this transmembrane
protein may have an enzymatic function within the
complex. This postulated novel function for aph-1
needs to be validated by future studies.
Presenilin Enhancer 2 (pen-2): the elusive
presenilinase or ‘‘molecular clamp’’ that holds the
complex together?
The pen-2 protein is a ~12 kDa, 101 amino acid long
protein containing two transmembrane domains and its
N- and C-terminals facing the lumen of the endoplas-
mic reticulum [74, 75]. Pen-2 has been shown to
interact with Nicastrin, aph-1, and also PS1. Without
this interaction pen-2 has been shown to be degraded,
possibly by the proteasome [76, 77]. Ablation of pen-2
results in significantly reduced PS1 endoproteolysis and
Ab production, suggesting that pen-2 is essential for
both presenilinase and c-secretase activity [15, 19, 22–
24]. Likewise, combinational expression studies have
shown that when pen-2 is co-expressed with the other
components of the c-secretase complex in a step-wise
manner, endoproteolysis of the PS1 holoprotein was
enhanced [11, 22, 24–27, 71]. A trimeric sub-complex
between presenilin, nicastrin and aph-1 has been
identified in cells lacking pen-2 [24, 70] suggesting that
pen-2 may be the final protein incorporated into the c-
secretase complex (Fig. 1). Recent evidence has sug-
gested that pen-2 is incorporated into the c-secretase
complex through an interaction with presenilins. The
‘‘DYLSF’’ domain of pen-2 and a ‘‘NF’’ motif on
transmembrane 4 of PS1 have been shown to be critical
for the interaction between these proteins [78–80]. The
cleavage of PS1 occurs within the hydrophilic loop and
is distal from the interaction site on transmembrane 4,
suggesting that another domain of pen-2 is responsible
for the cleavage of PS1 or pen-2 may present PS1 to the
elusive ‘‘presenilinase’’ which may be another member
of the c-secretase complex. The C-terminal end of pen-
2 has been shown to be important for c-secretase
activity since altering the length of this region by
addition or deletion of residues has been shown to
reduce Ab40 and 42 generation without altering the
binding of pen-2 to the complex [78] suggesting that
pen-2 may have an alternative function within the
complex. One suggestion put forward by Hasegawa
and colleagues [78] is that the C-terminus of pen-2 may
be a linker/space molecule that maintains spatial
interactions between proteins within the complex.
However, recent evidence using pen-2 C-terminal loss
of function mutations suggest that the C-terminus acts
as a ‘‘molecular clamp’’ holding together the presenilin
fragments and the whole c-secretase complex [81]. If
this is the case then PEN-2 is an integral part of the
catalytic process holding the complex together whilst
the c-secretase products are generated.
The newest member of the complex: TMP21,
a modulator of c-secretase activity
Recently another member of the c-secretase complex
was immuno-purified from wild-type PS1 and PS2
blastocyte derived cells [82]. The type 1 transmem-
brane protein termed TMP21 is a member of the p24
cargo-family which may have a signalling role in the
sorting and transport of proteins from the endoplasmic
reticulum to the Golgi [83, 84]. It was shown by Chen
and colleagues [82] that TMP21 is a member of the
complex as it was isolated in a high molecular weight
presenilin complex, interact with all of the known
components of the c-secretase complex, co-localised
with the complex components in the ER, Golgi and cell
surface and destabilised from the complex in the
absence of the presenilins and pen-2. Although the
over-expression of TMP21 did not alter c-secretase
activity, its suppression resulted in and increase in
Ab40 and Ab42. However, suppression of TMP21 did
not alter the production of AICD, notch cleavage to
generate NICD or cleavage of E-cadherin to generate
CICD. These results are consistent with the notion that
c- and -secretase cleavage activities are independently
regulated and indicate a role for TMP21 in modulating
c-secretase activity to generate Ab. This role for
TMP21 appears to be independent of its role in protein
transport since the suppression of both TMP21 and
p24a (a member of the p24 cargo family that interacts
with TMP21) does not result in additional increases in
Ab production to that observed following the sup-
pression of TMP21 only [82]. This finding led the
authors to postulate that there are two pools of
TMP21, a major pool that is stabilised by, p24a and has
Neurochem Res (2007) 32:609–623 613
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no role in Ab production and a minor pool that mod-
ulates Ab production, independent of p24a. Although,
further investigation is required to determine the pre-
cise mechanism of action, it appears that TMP21 may
function to regulate intramembrane proteolysis con-
trolling c-secretase activity and thus preventing the
over-production of Ab. This modulator role for TMP21
is important to consider when elucidating mechanisms
on how c-secretase activity is altered (for example by
presenilin mutations) resulting in enhanced Ab40 and
Ab42 production.
Presenilin 2 (PS2): capable of forming a fully
functional c-secretase complex
The presenilin proteins share an overall homology of
67% with the highest similarities in the predicted
transmembrane domains. Fewer similarities are found
at the N-terminus and in the central region of the
hydrophilic loop [85, 86]. Although there are some
structural similarities between PS1 and PS2 several
lines of evidence suggest that these proteins may have
distinct functions. Mice lacking PS1 die before birth
and have severe skeletal and brain deformities, whilst
those lacking PS2 only develop a mild pulmonary
fibrosis and haemorrhage with age [33, 87–90]. Com-
pared to neuronal cultures isolated from PS1 ablated
mice, those isolated from PS2 knockout mice exhibit
higher Ab production and are less sensitive to c-sec-
retase inhibitors [89, 91]. Lai and colleagues [91] also
provided evidence to suggest that distinct PS1 con-
taining and PS2 containing complexes exist [91]. If this
is the case, evidence to date suggests that PS2 con-
taining complexes have different functions and have
less c-secretase processing power than PS1 containing
complexes. However, recent in vitro evidence has
suggested that chimeras of PS1 and PS2 fragments
retain c-secretase activity [92] suggesting that active
complexes containing both PS1 and PS2 could occur.
However, this is unlikely to occur in vivo as PS2 and
PS1 transgenic mice have differential effects on c-sec-
retase activity [93]. In this study mice lacking PS1 were
crossbred with transgenic mice containing wild type or
mutant PS2/PS1. Compared to mice harbouring wild-
type PS1, those harbouring wild-type PS2 had a ~4-fold
reduction in Ab40 and ~2-fold reduction Ab42 brain
levels. In addition, the authors reported that although
mutations in PS1 lead to higher brain levels of Ab40
and Ab42 than PS2 mutations, those mice harbouring
PS2 mutations had higher brain levels of Ab42, whilst
Ab40 brain levels remain unchanged [93]. Taken
together these studies suggest that PS1 containing
complexes predominate in generating Ab40 and Ab42.
However, the finding that PS2 is involved in Ab42 (but
not Ab40) generation suggests that two Ab generating
c-secretase complexes (c-40 secretase and c-42 secre-
tase) exist, with c-42 secretase complexes containing
both PS1 and PS2.
The roles of presenilin binding proteins not
incorporated into the active c-secretase complex
In addition to Ab generation, the presenilins have been
implicated in a variety of intracellular processes
including membrane trafficking, Notch signalling,
neuronal plasticity, cell adhesion, regulation of calcium
homeostasis, the unfolded protein response, and
apoptosis. Therefore it is not surprising that the pre-
senilins have a growing list of binding partners (see
Table 1). Though the presenilin binding proteins that
are incorporated into the c-secretase complex are
critical for the activity of this enzyme, those that are
not integral components have equally important roles
in modulating Ab production. A number of non-com-
plex presenilin binding proteins have been shown to
alter c-secretase activity (see Table 1). However, only
a few have had supporting evidence that their direct
interaction with the presenilins modulate c-secretase
activity. These are described below and shown in
Fig. 2.
Calsenilin
Calsenilin (also called DREAM or kChIP3) is a cal-
cium binding protein, that was first identified through
yeast two hybrid screening using the PS2 C-terminus as
the bait protein [94]. The interaction between calseni-
lin and the presenilins appear to have a role in APP
processing. It was initially demonstrated that calsenilin
can form a complex with PS1 and PS2 and regulate
presenilin fragment formation in mammalian cells [95].
This study also showed that calsenilin may facilitate
presenilin mediated apoptosis, since calsenilin was
shown to preferentially interact with the C-terminal
fragment of PS2 that results from caspase cleavage of
the presenilin holoprotein [96]. Expression studies in
vivo (Xenopus) and in vitro (mammalian cells) have
shown that the interaction between presenilin and
calsenilin may be involved in ER calcium release and
apoptosis [97, 98]. Over-expressing calsenilin in neu-
ronal cells resulted in cell death which was enhanced
by the co-expression of wild-type or PS1 mutations
[99]. These studies have suggested that the interaction
between calsenilin and presenilins may function in
apoptotic pathways. However, several lines of evidence
614 Neurochem Res (2007) 32:609–623
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Table 1 Presenilin interacting proteins






APH-1 Component of the c-secretase complex; role for initial
formation of the complex, or a proteolytic role
Yes [19, 65, 67, 123].
Nicastrin Component of c-secretase complex; possible role
as a receptor for APP-C99
Yes [14, 55–58].
PEN-2 Component of the c-secretase complex, role in
proteolytic cleavage of the presenilins
Yes [19, 24, 70, 76, 77].
TMP21 Recently identified component of the c-secretase
complex, role in modulating Ab production
Yes [82]
c-secretase substrates
APP-C99 Substrate for the c-secretase complex:
precursor to Ab generation
Yes [38–40]
E/N cadherin c-secretase substrate; role in Cell-Cell Adhesion No [124]
IRE1 c-secretase substrate; role in unfolded protein response No [125, 126]
LRP c-secretase substrate; Lipid metabolism Yes [119]
Notch1 c-secretase substrate; precursor to NICD generation Yes [112]
Interacting binding proteins
ABP-280, Filamin homolog1 Actin binding protein No [127]
Bcl-2 Anti-apoptotic molecule No [128]
Bcl-XL Anti-apoptotic molecule No [129]
Calmyrin Possible calcium-myrstol switch No [130]
CALP- calsenilin like protein Novel member of the calsenilin/KChIp protein family No [131]
Calsenilin Calcium binding protein Yes [94, 96–99, 101, 102]
CLIP-170 Linking membrane organelles to microtubules No [132]
DRAL LIM-domain containing protein No [133]
FHL2 Role in PI3K/Akt activation No [134]
FKBP38 Role in mitochondria mediated apoptosis No [135]
Go Signalling molecule No [136]
GSK3b Wnt signalling, serine threonine protein kinase No [137]
HC5/ZETA Subunits of the catalytic 20S proteasome Yes [138]
Met1 Putative methyltransferase No [139]
Modifier of cell adhesion
protein (MOCA)
Regulates proteasomal activity on APP Yes [140]
Omi/HtrA2 Serine protease, proapoptotic No [141]
PAG Neuronal proliferation protein No [142]
PAMP and PARL Metalloproteases No [143]
PKA Serine/Theronine protein kinase;
b-catenin phosphorylation
No [144]
Plakoglobin Role in b-catenin/Tcf-4 activity No [145]
PLD1 Phospholipid-modifying enzyme Yes [146]
PSAP PDZ like protein No [147]
QM/Jif1 Negative regulator of c-Jun No [148]
Rab proteins Vesicle mediated protein trafficking Yes [149, 150]
RyR2 Cardiac ryanodine receptor No [151]
SEL-10 Ubiquitination of proteins Yes [152]
Sorcin Calcium binding regulator of ryanodine receptor No [153]
Syntaxin 1A Synaptic plasma-membrane protein No [154]
Syntaxin 5 ER-Golgi vesicular transport Yes [155, 156]
Tau Microtubule binding protein No [137]
Telencephalin Neuron specific adhesion molecule No [40]
TPIP Tetratricopeptide repeat-containing protein No [157]
Ubiquilin Ubiquitin domain-containing protein No [158–160]
X11 family of proteins Cytoplasmic adaptor proteins Yes [110, 111]
b-catenin/d-catenin (NPARP) Wnt signalling. Cell adhesion No [161–163]
l-Calpain Calcium-dependent thiol protease No [164]
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suggest that calsenilin may also be implicated in APP
processing and Ab generation. Initial in vitro studies
showed that over-expression of calsenilin in mouse
neuroblastoma cells resulted in a gene dose dependent
accumulation of Ab42 [100]. Using a c-secretase
luciferase based assay and a cell free system estab-
lished by Li and colleagues [18] to characterise the c-
secretase complex in purified cell membranes, Jo and
colleagues [101] recently reported that the over-
expression of calsenilin resulted in an increase in c-
secretase activity. This calsenilin/presenilin, mediated
activity was markedly reduced using a well-character-
ised c-secretase inhibitor (L-685, 458). Furthermore,
compared to wild-type mice, brain Ab40 and Ab42
levels were reduced in calsenilin ablated mice [102].
Together these studies would suggest that calsenilin
has a second function, to facilitate c-secretase activity.
X11/Mint proteins
A family of cytoplasmic adaptor proteins called X11
(also known as munc-18-interacting proteins—mints)
have also shown to have a direct role in APP pro-
cessing. In particular, several studies have reported
that X11a and X11b stabilise APP and inhibit the
secretion of Ab and APP from neuronal cells [103–
106]. The molecular mechanisms by which the X11s
influence APP processing and Ab production are not
clear. However, this effect appears to be modulated by
a direct interaction between X11 and APP. The inter-
action between the phosphotyrosine binding (PTB)
domain within X-11 and the YENPTY motif within
APP appears to modulate Ab generation, since intro-
duction of point mutations within these domains
enhanced Ab generation [103, 106–109]. The binding
Fig. 2 The postulated roles for presenilin interacting proteins
not incorporated into the c-secretase complex in Ab generation.
A schematic representation of the postulated roles of presenilin
interacting proteins in (A) promoting or (B) attenuating c-
secretase activity and Ab generation. (A) Together with the
formation of the c-secretase complex, calsenilin have been
shown to interact with the presenilins and promote Ab
generation when over-expressed in mammalian cells. The role
of calsenilin in Ab generation remains unclear but maybe
involved in the presentation of the substrate to the c-secretase
complex. (B) The presenilin interacting protein, X11 and other c-
secretase substrates that compete for enzyme activity such as
Notch fragments (i.e. NEXT) have all been shown to reduce Ab
generation when over-expressed in mammalian cells. X11 may
reduce Ab production by binding to PS and APP preventing PS
mediated cleavage of APP or its presentation to the c-secretase
complex
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of X11 appears to stabilise APP, leading to its intra-
cellular accumulation [103, 106–109]. It is conceivable
that the X11–APP interaction may inhibit secretase
accessibility to APP resulting in impaired Ab secretion.
The X11 proteins have multiple binding domains and
have been shown to interact with the PS1 C-terminal
fragment through their PDZ domain [110]. The
authors also showed an interaction between PS1 and
APP in the presence of X11 that was otherwise ablated
in the absence of X11. This suggests that an interaction
between APP and PS1 is mediated through X11. A
subsequent study has reported that X11b and alcadein
(and X11b-binding protein) expression prevents the
binding of PS1 to APP [111]. The significance of the
results from these interaction studies remains unclear.
However, they do suggest that X11 proteins may act as
inhibitory molecules preventing PS1 mediated proteo-
lytic processing of APP and thus attenuating Ab
production.
Competing substrates
Some presenilin binding proteins reduce the likelihood
of Ab generation by competing for the catalytic activity
offered by c-secretase. One example is Notch1 which
undergoes cleavage by c-secretase to liberate an
intracellular domain (NICD) that translocates to the
nucleus where it co-activates transcription of genes
involved in several developmental pathways [112–115].
The first evidence of substrate competition came from
one study that treated neurons with the Noch1 ligand,
delta, and found a dose dependent reduction in Ab
levels [116]. In contrast, the over-expression of APP in
these neurons resulted in a reduction in Notch signal-
ling [116]. Further evidence for substrate competition
was provided by Kimberley and colleagues [117] where
APP and Notch based substrates directly competed for
c-secretase activity in a cell free assay. Similar results
were achieved in a subsequent study where cells
expressing Notch showed a reduction in Ab production
[118]. Additional evidence for substrate competition
has been provided recently for another substrate of c-
secretase, the cytoplasmic tail of the low-density lipo-
protein receptor—related protein (LRP), which has
also been shown to interact with PS1 [119]. The co-
expression of the LRP C-terminal fragment and APP
in CHO cells has been shown to result in a reduction in
secreted levels of Ab40 and Ab42 [119].
Taken together, these studies not only suggest sub-
strate competition but also the presence of a single
c-secretase. However, the presence of multiple c-sec-
retase complexes cannot be ruled out. As discussed
above there is evidence in the literature for the
formation of c-secretase complexes with distinct func-
tions. All of the studies described above are undertaken
in conditions where there is a large amount of substrate
available which could down-regulate the activity of one
c-secretase for another. Whether substrate competition
occurs under physiological conditions and if there are
certain conditions that promote a higher expression of
one substrate over another remains to be determined.
Concluding comments
It is well established that together with presenilin, its
binding proteins, nicastrin, aph-1 and pen-2 are the only
proteins that constitute the c-secretase complex
responsible for generating Ab from APP. The func-
tion(s) of each c-secretase component within the com-
plex is gradually becoming apparent. However, there
are many facets of c-secretase activity that are yet to be
identified such as the domain responsible for actual
catalytic activity; the mechanisms of enzymatic activity
within the lipid bi-layer; and the existence of single or
multiple c-secretase complexes. Further investigation
using appropriate protein expression models and
reconstitution studies such as those used to validate the
protein components of c-secretase complex is required
to provide some insight into the processes that underlie
the catalytic activity of this enzyme. Indeed, reconsti-
tution of the c-secretase complex in insect cells and
purification of this complex from the cells have provided
researchers with the first 3D images of the structure of
this intricate enzyme [120, 121]. Identification of the
specific catalytic domain(s) within the complex would
provide a site that could be a potential target to develop
agents that specifically modulate Ab levels without
altering the other known (and unknown) activities of the
c-secretase enzyme. Recent insight into this notion was
provided by the finding that certain compounds selec-
tively block the cleavage of APP but not Notch [122].
However, it is important to note that other presenilin
interacting proteins not incorporated into the complex
and the pathways they are involved in play important
roles in APP processing and Ab generation. These
interactions assist in many facets of c-secretase activity,
including modulating substrate/enzyme availability, and
thus are important to consider when developing
appropriate therapeutic strategies.
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